tradingkey.logo
tradingkey.logo
Search

Harvard Bioscience Inc

HBIO
Add to Watchlist
6.100USD
+0.010+0.16%
Close 07-31 16:00ETQuotes delayed by 15 min
27.51MMarket Cap
LossP/E TTM

HBIO Financials

See Harvard Bioscience Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Harvard Bioscience Inc Earnings Date

Latest Release
Aug 11, 2026
EPS / Forecast
--/-0.21
Revenue / Forecast
--/21.45M
Period
FY2025 Earnings
Revenue(YoY)
86.55M
-8.06%
EPS(YoY)
-12.77
-348.30%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
93.29%-0.77
-15668.29%-0.64
74.90%-0.28
23.47%-0.52
-955.57%-11.42
100.96%0.00
-279.39%-1.10
-190.88%-0.67
-7422.27%-1.08
-964.42%-0.43
---0.29
---0.23
--0.01
---0.04
----
----
----
----
----
----
Revenue
-4.68%20.75M
-3.34%23.73M
-6.27%20.59M
-11.46%20.45M
-11.17%21.77M
-12.78%24.56M
-13.38%21.97M
-19.69%23.10M
-18.23%24.51M
-0.96%28.15M
-5.79%25.36M
-1.54%28.76M
4.16%29.98M
-14.00%28.43M
-9.24%26.92M
0.04%29.21M
6.63%28.78M
6.68%33.05M
23.41%29.66M
25.27%29.20M
Net Profit
93.20%-3.42M
-15916.67%-2.85M
74.36%-1.23M
22.04%-2.28M
-972.43%-50.34M
100.99%18.00K
-287.57%-4.80M
-198.67%-2.93M
-854.66%-4.69M
-9.12%-1.82M
63.61%-1.24M
-140.25%-980.00K
109.04%622.00K
-273.36%-1.67M
-1902.94%-3.41M
693.90%2.44M
-928.40%-6.88M
256.26%961.00K
84.52%-170.00K
74.07%-410.00K
Net Margin
92.86%-16.50%
-16464.17%-11.99%
72.65%-5.98%
11.94%-11.16%
-1107.29%-231.19%
101.14%0.07%
-347.45%-21.86%
-271.89%-12.67%
-1022.86%-19.15%
-10.19%-6.46%
---4.89%
---3.41%
--2.08%
---5.86%
----
----
----
----
----
----
Gross Margin
8.72%55.04%
8.07%56.13%
4.23%54.23%
-1.46%50.71%
-7.66%50.63%
-2.11%51.94%
-1.27%52.03%
-3.16%51.47%
-3.09%54.83%
6.20%53.06%
--52.70%
--53.15%
--56.57%
--49.96%
----
----
----
----
----
----
Debt to assets ratio
3.11%46.46%
53.52%44.80%
50.98%43.55%
57.27%43.53%
68.50%45.06%
9.63%29.18%
4.04%28.85%
-4.52%27.68%
-11.63%26.74%
-17.37%26.62%
--27.73%
--28.99%
--30.26%
--32.21%
----
----
----
----
----
----
Revenue
-4.68%20.75M
-3.34%23.73M
-6.27%20.59M
-11.46%20.45M
-11.17%21.77M
-12.78%24.56M
-13.38%21.97M
-19.69%23.10M
-18.23%24.51M
-0.96%28.15M
-5.79%25.36M
-1.54%28.76M
4.16%29.98M
-14.00%28.43M
-9.24%26.92M
0.04%29.21M
6.63%28.78M
6.68%33.05M
23.41%29.66M
25.27%29.20M
Operating profit
42.18%-939.00K
657.46%1.73M
114.45%245.00K
52.84%-789.00K
28.74%-1.62M
-19.15%228.00K
-81.67%-1.69M
-310.18%-1.67M
-230.30%-2.28M
161.71%282.00K
78.33%-933.00K
190.25%796.00K
214.99%1.75M
-126.91%-457.00K
-817.67%-4.31M
-220.99%-882.00K
-584.39%-1.52M
-41.33%1.70M
19.76%600.00K
-44.10%729.00K
Net Profit
93.20%-3.42M
-15916.67%-2.85M
74.36%-1.23M
22.04%-2.28M
-972.43%-50.34M
100.99%18.00K
-287.57%-4.80M
-198.67%-2.93M
-854.66%-4.69M
-9.12%-1.82M
63.61%-1.24M
-140.25%-980.00K
109.04%622.00K
-273.36%-1.67M
-1902.94%-3.41M
693.90%2.44M
-928.40%-6.88M
256.26%961.00K
84.52%-170.00K
74.07%-410.00K
Current assets
5.74%47.48M
6.89%48.23M
-6.38%43.80M
-3.15%44.97M
-6.74%44.90M
-8.00%45.12M
-7.32%46.79M
-11.76%46.43M
-8.20%48.15M
-4.08%49.04M
-2.57%50.49M
-6.87%52.62M
-11.77%52.45M
-16.98%51.12M
-6.95%51.82M
5.49%56.50M
20.77%59.45M
19.12%61.58M
27.95%55.69M
21.44%53.56M
Total current liabilities
-57.08%23.86M
-60.04%21.96M
139.09%54.40M
144.03%55.20M
116.55%55.60M
107.06%54.96M
-6.01%22.75M
-1.40%22.62M
10.60%25.68M
14.16%26.54M
13.32%24.20M
-1.76%22.94M
-14.72%23.22M
-8.16%23.25M
-9.13%21.36M
0.37%23.35M
31.41%27.23M
20.25%25.32M
10.63%23.51M
2.67%23.27M
Total assets
-2.33%77.94M
-36.77%80.07M
-40.57%77.99M
-37.87%80.09M
-40.07%79.80M
-7.81%126.64M
-6.08%131.24M
-9.79%128.91M
-8.53%133.16M
-5.50%137.37M
-4.95%139.74M
-7.97%142.90M
-7.89%145.58M
-10.46%145.36M
-4.46%147.01M
0.85%155.27M
4.49%158.04M
3.90%162.34M
2.85%153.87M
2.18%153.97M
Total liabilities
4.50%67.89M
4.79%66.34M
-3.02%63.92M
4.37%64.36M
0.96%64.97M
-1.54%63.30M
0.72%65.92M
-8.66%61.66M
-9.67%64.35M
-12.10%64.29M
-12.77%65.45M
-13.19%67.51M
-12.77%71.24M
-7.35%73.14M
-2.53%75.03M
3.32%77.77M
10.16%81.67M
-0.79%78.94M
6.26%76.98M
0.88%75.27M
Total equity
-32.28%10.05M
-78.32%13.73M
-78.46%14.07M
-76.60%15.73M
-78.44%14.84M
-13.32%63.34M
-12.07%65.32M
-10.80%67.25M
-7.44%68.81M
1.18%73.07M
3.21%74.29M
-2.73%75.39M
-2.66%74.34M
-13.41%72.22M
-6.38%71.98M
-1.52%77.50M
-0.96%76.38M
8.76%83.40M
-0.36%76.89M
3.46%78.70M
Net operating income
-122.17%-662.00K
-105.57%-96.00K
228.74%1.08M
425.65%2.75M
112.83%2.99M
-59.91%1.73M
-119.31%-842.00K
-123.82%-846.00K
-22.57%1.40M
60.62%4.30M
571.96%4.36M
1969.47%3.55M
191.24%1.81M
2189.74%2.68M
198.33%649.00K
-124.74%-190.00K
-291.51%-1.99M
-95.30%117.00K
-141.33%-660.00K
-67.64%768.00K
Net investment
9.22%-620.00K
-28.54%-599.00K
68.68%-348.00K
-150.87%-233.00K
-203.56%-683.00K
56.08%-466.00K
-177.06%-1.11M
173.28%458.00K
-178.13%-225.00K
-351.49%-1.06M
9.28%-401.00K
-41.40%-625.00K
161.15%288.00K
34.36%-235.00K
7.92%-442.00K
-114.56%-442.00K
-56.48%-471.00K
-14.01%-358.00K
14.89%-480.00K
27.21%-206.00K
Net financing
99.25%-9.00K
280.47%2.45M
-160.74%-1.28M
-810.73%-1.26M
-14.12%-1.20M
67.03%-1.36M
176.51%2.10M
107.45%177.00K
63.53%-1.05M
-50.77%-4.12M
-829.44%-2.75M
-310.90%-2.38M
-3177.66%-2.89M
-205.24%-2.73M
-22.59%377.00K
-201.04%-578.00K
102.99%94.00K
-22.73%2.59M
151.10%487.00K
96.38%-192.00K

FAQs

What is the total revenue of Harvard Bioscience Inc?

According to Harvard Bioscience Inc's FY2025 earnings report, its total revenue reached 86.55M, with a year-on-year change of 94.14M.

What are the current assets of Harvard Bioscience Inc?

According to Harvard Bioscience Inc's FY2025 earnings report, its current assets were 48.23M, with a year-on-year change of 6.89.

What are the total assets of Harvard Bioscience Inc?

According to Harvard Bioscience Inc's FY2025 earnings report, its total assets of Harvard Bioscience Inc were 80.07M, with a year-on-year change of -36.77.

What are the total liabilities of Harvard Bioscience Inc?

According to Harvard Bioscience Inc's FY2025 earnings report, its total liabilities of Harvard Bioscience Inc were 66.34M, with a year-on-year change of 4.79.

What is the total equity of Harvard Bioscience Inc?

According to Harvard Bioscience Inc's FY2025 earnings report, its total equity of Harvard Bioscience Inc was 13.73M, with a year-on-year change of -78.32.

What is the net operating income of Harvard Bioscience Inc?

According to Harvard Bioscience Inc's FY2025 earnings report, its net operating income of Harvard Bioscience Inc was -441.00K, with a year-on-year change of 91.80.

What is the net investment of Harvard Bioscience Inc?

According to Harvard Bioscience Inc's FY2025 earnings report, its net investment of Harvard Bioscience Inc was -1.86M, with a year-on-year change of -38.62.

What is the net financing of Harvard Bioscience Inc?

According to Harvard Bioscience Inc's FY2025 earnings report, its net financing of Harvard Bioscience Inc was -1.29M, with a year-on-year change of -885.50.

What is the Earnings Per Share (EPS) of Harvard Bioscience Inc?

According to Harvard Bioscience Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -12.77, with a year-on-year change of -348.30.

What is the net income of Harvard Bioscience Inc?

According to Harvard Bioscience Inc's FY2025 earnings report, its net income was -56.70M, with a year-on-year change of -357.07.

What is the net margin of Harvard Bioscience Inc?

According to Harvard Bioscience Inc's FY2025 earnings report, its net profit margin was -65.51, with a year-on-year change of -397.13.

What is the gross margin of Harvard Bioscience Inc?

According to Harvard Bioscience Inc's FY2025 earnings report, its gross margin was 53.01, with a year-on-year change of 0.71.

What is the debt-to-asset ratio of Harvard Bioscience Inc?

According to Harvard Bioscience Inc's FY2025 earnings report, its debt-to-asset ratio was 44.80, with a year-on-year change of 53.52.

What is the Return on Equity (ROE) of Harvard Bioscience Inc?

According to Harvard Bioscience Inc's FY2025 earnings report, its Return on Equity (ROE) was -147.13, with a year-on-year change of -708.98.

What is the Return on Assets (ROA) of Harvard Bioscience Inc?

According to Harvard Bioscience Inc's FY2025 earnings report, its Return on Assets (ROA) was -54.86, with a year-on-year change of -483.76.

What is the operating profit of Harvard Bioscience Inc?

According to Harvard Bioscience Inc's FY2025 earnings report, its operating profit was -441.00K, with a year-on-year change of 91.80.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.